Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indian markets trade in the green
Thu, 6 Aug 01:30 pm

Indian Indices are trading positively in the post noon trading session. Sectoral indices are trading on a mixed note with stocks from the FMCG and mining sectors being the major losers.

The BSE-Sensex is trading up by 59 points (0.2%) and the NSE-Nifty is trading up by 25 points (0.3%). The BSE Mid Cap index and BSE Small Cap indices are trading marginally up. Gold prices, per 10 grams, are trading at Rs 24,694 levels. Silver price, per kilogram, is trading at Rs 33,467 levels. Crude oil is trading at Rs 2,879 per barrel. The rupee is trading at 63.79 to the US dollar.

Stocks in the engineering sector are trading mixed with Manugraph India and BGR Energy witnessing maximum selling pressure. As per a leading financial daily, technology, engineering, construction and manufacturing company Larsen & Toubro (L&T) has sought shareholders nod to raise up to Rs 36 bn through issue of securities. This is in order to meet its capital requirements of its growing business. Further, on a separate note, the company has divested its entire 13.66% stake in Salzer Electronics in a bulk deal through an open market transaction. Stock of Larsen & Toubro is presently trading up by 1.6%.

Pharma stocks are trading on a mixed note with Natco Pharma and Strides Acrolab leading the gains. According to financial times, Dr Reddy's Laboratories has entered into a strategic collaboration with Amgen to market and distribute three of its medicines in India in the areas of oncology and cardiology. Amgen is one of the world's leading independent biotechnology companies. The collaboration leverages the capabilities of both companies by combining three of Amgen's innovative therapies with Dr. Reddy's deep understanding of patient and physician needs in India. Currently the stock of Dr Reddy's Laboratories is trading up by 2.4%.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian markets trade in the green". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Agora Research Private Limited (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.